From our other sites
The story
After the finale of TBS’s Sunday drama “VIVANT” aired, it was announced that a theatrical film version would open on December 4, and when advance tickets went on sale nationwide at midnight on the 9th, theater after theater sold out. Theater staff reportedly were stunned, saying “the momentum is honestly incredible.” On 5ch, discussion centered on how the audience differs from that of the Godzilla film opening around the same time, speculation on whether box-office revenue could top ¥10 billion, and theories about why the production team chose a theatrical film over a third TV season — producing a mix of excitement and sober skepticism.
VIVANT the Movie Sees Advance Tickets Sell Out Nationwide — Theaters Stunned: “The Momentum Is Honestly Incredible…!”
The final episode of TBS’s Sunday drama slot series “VIVANT” (Sundays, 9:00 PM), starring actor Masato Sakai (53), aired on the 8th, and it was announced that a theatrical film version will open on December 4.
Advance ticket sales began nationwide at midnight on the 9th, and theater after theater sold out, underscoring just how frenzied the anticipation has become.
Source: news.yahoo.co.jp / Original article here
What people said
If it's got more screens, yeah, theoretically that'd be the case.
Women are going to see this, so isn't the audience way broader than Godzilla's? Feels closer to Chiikawa (the hit cute-character franchise).
TBS is probably aiming for ¥20 billion.
No way that's happening. Not a chance.
I get that the drama cost way more to produce than usual, so they want to recoup it with a movie, but with a film, whoever rushes to see it first just blasts spoilers all over social media. I would've rather had a Season 3 of the drama instead.
If even 10% of that remaining 20% who did watch go see it, that's already a massive hit.
It's basically just two episodes' worth of content, and they can reuse the drama's sets and cast, so there's plenty of time to shoot it.
Apparently they just filmed the movie footage during the same location shoots, and more than 30 minutes of the film is probably just a recap digest anyway, so it's probably not as much extra work as it sounds.
There was probably just an NDA in place — this was likely decided from the very start.
From Sanrio's earnings presentation… domestic sales of Pompompurin roughly doubled, while in China sales of My Melody rose 65%. [Shoukousan★]
https://hayabusa9.5ch.io/test/read.cgi/mnewsplus/1793958503/
It's only like 1,000 yen.
Too long a gap since the last one?
Maybe it's that the latest "Bayside Shakedown" just got terrible word of mouth on the content itself.
Building buzz with a TV drama series and then releasing a movie off the back of it — that's exactly the same formula "Bayside Shakedown" used, though.
All the people who've been yelling "TV is dead" are now gathered in the VIVANT thread swapping impressions with everyone else — that's the state of things.
In the same time slot, NHK's taiga drama hit a new low of 8.8%, while VIVANT's own promo special got 14.2%, and the VIVANT main episode got 21.8%. Apparently the public would rather watch Masato Sakai and Hiroshi Abe doing promo appearances than "Toyotomi Brothers," starring Taiga Nakano, Soichiro Ikematsu, Ryosuke Yamada, Kohei Matsushita, Kento Shibuya, and Jin Shirasu. That says a lot.
I'd guess ticket numbers could be on par with Kokuho, but I can't see VIVANT having repeat viewers, so ¥10 billion is a no-go.
They run the bonus-merch-to-drive-repeat-viewing strategy for like two months these days though.
You can't pause or rewind in a theater, so I think the theory-crafting crowd will keep showing up for a while. And beyond the 4th viewing, they'll probably hand out a settings/lore booklet as a bonus.
But beating Kokuho is totally out of reach. Season 2 — if it hadn't had the villains' boardroom scenes, I would've dropped it.
It's selling plenty well even at theaters outside the big cities.
If Masato Sakai shows up at the end of the screening and says "There's still more to come! See you at the final chapter!!" — that would go down in film history.
Background and Key Points of This Discussion
“VIVANT” originally aired on TBS’s Sunday drama slot in 2023 and drew high ratings both in Japan and abroad; the theatrical film’s release was decided following the finale of its sequel drama. It’s easy to overlook that the advance-ticket “sellout” refers only to certain theaters and certain showtimes before release, not a guarantee of nationwide box-office results. Thread opinion split over the scale of box-office revenue, ranging from treating ¥10 billion as a reasonable ceiling to skepticism toward the ¥20 billion theory. Even with roughly 80% of people reportedly not having watched the drama, the point that “it’s already a smash hit if even a slice of the remaining 20% show up” offered a useful way to think about the relationship between TV ratings and movie attendance. Meanwhile, comparisons to “Bayside Shakedown” and “Kokuho” came up as reminders that a film’s worth can’t be measured by box office alone.
*This article is excerpted and summarized from the 5ch (Entertainment & Sports News+) thread “[Movie] Masato Sakai-led theatrical film VIVANT sees advance tickets sell out nationwide… Theaters stunned: “The momentum is honestly incredible!”.”
Leave a Reply